<SEC-DOCUMENT>0001628280-20-004724.txt : 20200407
<SEC-HEADER>0001628280-20-004724.hdr.sgml : 20200407
<ACCEPTANCE-DATETIME>20200407080804
ACCESSION NUMBER:		0001628280-20-004724
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20200407
FILED AS OF DATE:		20200407
DATE AS OF CHANGE:		20200407

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALCON INC
		CENTRAL INDEX KEY:			0001167379
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				980205094
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31269
		FILM NUMBER:		20778438

	BUSINESS ADDRESS:	
		STREET 1:		6201 SOUTH FREEWAY
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76134
		BUSINESS PHONE:		817 293 0450

	MAIL ADDRESS:	
		STREET 1:		CHEMIN DE BLANDONNET 8
		STREET 2:		1214 VERNIER
		CITY:			GENEVA
		STATE:			V8
		ZIP:			0000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-k7apr2020.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sDA1FBE7843F055D6A62122CAA17312AC"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:Open Sans,sans-serif;font-size:16pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:Open Sans,sans-serif;font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">_________________</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:22pt;"><font style="font-family:Open Sans,sans-serif;font-size:22pt;font-weight:bold;">FORM 6-K </font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">_________________</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:13pt;"><font style="font-family:Open Sans,sans-serif;font-size:13pt;font-weight:bold;">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="line-height:120%;text-align:center;font-size:13pt;"><font style="font-family:Open Sans,sans-serif;font-size:13pt;font-weight:bold;">PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE</font></div><div style="line-height:120%;text-align:center;font-size:13pt;"><font style="font-family:Open Sans,sans-serif;font-size:13pt;font-weight:bold;">SECURITIES EXCHANGE ACT OF 1934</font></div><div style="line-height:120%;text-align:center;font-size:13pt;"><font style="font-family:Open Sans,sans-serif;font-size:13pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;font-weight:bold;">April 7, 2020</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;font-weight:bold;">Commission File Number: 001-31269 </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">_________________</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:22pt;"><font style="font-family:Open Sans,sans-serif;font-size:22pt;font-weight:bold;">ALCON INC. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">(Registrant Name)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;font-weight:bold;">Chemin de Blandonnet 8</font><font style="font-family:Open Sans,sans-serif;font-size:10pt;">&#32;<br></font><font style="font-family:Open Sans,sans-serif;font-size:10pt;font-weight:bold;">1214 Vernier, Geneva, Switzerland </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">(Address of principal executive office)</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">_________________</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20&#8209;F or Form 40-F:  Form 20-F </font><font style="font-family:Open Sans,sans-serif;font-size:11pt;">&#32;&#32;&#32;</font><font style="font-family:Open Sans,sans-serif;font-size:11pt;text-decoration:underline;">x</font><font style="font-family:Open Sans,sans-serif;font-size:11pt;">&#32;&#32;&#32;&#32;</font><font style="font-family:Open Sans,sans-serif;font-size:11pt;">&#32;&#32;Form 40-F </font><font style="font-family:Open Sans,sans-serif;font-size:11pt;text-decoration:underline;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): </font><font style="font-family:Open Sans,sans-serif;font-size:11pt;text-decoration:underline;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): </font><font style="font-family:Open Sans,sans-serif;font-size:11pt;text-decoration:underline;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="s798B1452708B564CA7B14DD48F0F9A0A"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:12%;"></td><td style="width:3%;"></td><td style="width:85%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Exhibit</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Number</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="pressrelease-covidx19.htm"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">99.1</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Press release issued by Alcon Inc. dated April 7, 2020 titled &#8220;Alcon provides update on COVID-19&#8221;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div><a name="s31531F1D8CBD5CEA9AB85F16885884F4"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:7%;"></td><td style="width:24%;"></td><td style="width:24%;"></td><td style="width:4%;"></td><td style="width:41%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;font-weight:bold;">ALCON INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">April 7, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">/s/ Timothy C. Stonesifer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Name: Timothy C. Stonesifer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Title: Authorized Representative</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">April 7, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">/s/ Royce Bedward</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Name: Royce Bedward</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">Title: Authorized Representative</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:384px;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Open Sans,sans-serif;font-size:10pt;">3</font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressrelease-covidx19.htm
<DESCRIPTION>EXHIBIT 99.1 - ALCON PROVIDES UPDATE ON COVID-19
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s74B2E7CFC1FBE529D5DC5159B674463E"></a></div><div><div style="line-height:120%;text-align:center;"><img src="pressreleaseagmcovid4_image3.gif" alt="pressreleaseagmcovid4_image3.gif" style="height:293px;width:816px;"></div></div><div><br></div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:8pt;"><font style="font-family:Open Sans,sans-serif;font-size:8pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:center;font-size:17pt;"><font style="font-family:Open Sans,sans-serif;font-size:17pt;color:#003595;font-weight:bold;">Alcon provides update on COVID-19</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:Open Sans,sans-serif;font-size:12pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Open Sans,sans-serif;font-size:12pt;font-weight:bold;">Due to uncertainty around impact of COVID-19, previous 2020 guidance is withdrawn</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:Open Sans,sans-serif;font-size:12pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Open Sans,sans-serif;font-size:12pt;font-weight:bold;">In lieu of attendance at the Annual General Meeting, Alcon shareholders are directed to exercise voting rights exclusively via independent representative</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:Open Sans,sans-serif;font-size:12pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Open Sans,sans-serif;font-size:12pt;font-weight:bold;">To maintain financial flexibility, company is implementing cash preservation measures which includes delaying initiation of a dividend proposal until 2021 </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:Open Sans,sans-serif;font-size:12pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Open Sans,sans-serif;font-size:12pt;font-weight:bold;">Alcon Foundation is supporting relief efforts and donating supplies to help those impacted by global pandemic</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;color:#00aeef;font-weight:bold;">Geneva, April 7, 2020</font><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">&#32;&#8211; Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced a series of updates stemming from the impact of COVID-19.</font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">First and foremost, Alcon&#8217;s top priority is protecting the safety of its associates and the communities it serves. As a result, the company has initiated business continuity plans designed to keep its associates and customers safe while continuing to deliver critical eye care needs for the global healthcare community. These plans include directing all Alcon office-based associates to work from home and not travel. In manufacturing facilities, the company is limiting the number of people in one area at a time, modifying workstation arrangements and minimizing the cross flow of people between shifts to reduce potential exposure, along with enhanced cleaning and sanitization.</font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;color:#003595;font-weight:bold;">2020 Guidance</font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">Alcon today announced it is withdrawing its full year 2020 guidance previously disclosed on February 25, 2020. </font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">Most countries and local municipalities have mandated or advised unprecedented measures to help contain the spread of COVID-19. These measures, which have necessitated a temporary deferral of eye care procedures and exams in many markets, are anticipated to have an impact on Alcon&#8217;s financial results. The extent of this impact will depend on the duration of the pandemic, timing of global recovery and normalization of customers&#8217; practices. Due to the challenges in forecasting the duration of the pandemic, Alcon is unable to estimate the overall ongoing impact on its financial results. The company plans to provide additional details in its first quarter earnings call scheduled for May 13, 2020. </font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;color:#003595;font-weight:bold;">Annual General Meeting and Withdrawal of Dividend Proposal</font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">Alcon&#8217;s Board of Directors announced the company will hold its first Annual General Meeting on Wednesday, May 6, 2020, without the attendance of shareholders and published its invitation for shareholders in the Swiss Gazette of Commerce.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">Due to restrictions banning all public and private events in Switzerland as a result of the coronavirus outbreak, the Board of Directors is directing shareholders to send their voting instructions to the independent representative, Hartmann Dreyer Attorneys-at-Law. Shareholders will not be granted access to the meeting room on the day of the meeting.</font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">Alcon&#8217;s Board of Directors has also revised the proposals for the meeting. In February, the Board proposed a dividend of CHF 0.19 per share for 2019. In light of the current market conditions and economic uncertainties linked to COVID-19, and as part of the company&#8217;s overall efforts to maintain financial flexibility and implement cash preservation measures, the Board of Directors considers that it is in the best interest of Alcon's stakeholders to delay the initiation of a dividend proposal until 2021. As a result, the dividend proposal has been withdrawn and the remaining amount of available earnings, after allocation to the general reserve, shall be carried forward.</font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">The invitation, including agenda, proposals of the Board of Directors and other meeting materials covering the COVID-19 situation and the withdrawal of the dividend proposal, will soon be mailed directly to shareholders entered in the company&#8217;s share register with the right to vote as of the record date of April 27, 2020. The meeting materials will soon be available electronically for information purposes on </font><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;color:#262fdd;">https://investor.alcon.com/news-and-events/events-and-presentations/event-details/2020/2020-Annual-General-Meeting/default.aspx</font><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">Alcon regrets the unusual circumstances of the 2020 Annual General Meeting and hopes to return to a standard agenda next year.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;color:#003595;font-weight:bold;">COVID-19 Support Efforts</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">Alcon is responding by supporting charitable partners that are serving the most vulnerable populations affected by the outbreak. The Alcon Foundation has reallocated funds and made monetary donations to local, national and global organizations to support meal programs for children and seniors, provide essential supplies to shelters and aid public health emergency relief efforts. </font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">As the public health emergency has grown in scale, Alcon has ramped up its efforts to donate personal protective equipment (PPE), while also producing additional PPE and hand sanitizers for relief efforts. Alcon will continue to explore additional measures to support organizations fighting to stem this pandemic.</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;color:#003595;font-weight:bold;text-decoration:underline;">Forward-looking Statements</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;commitment,&#8221; &#8220;look forward,&#8221; &#8220;maintain,&#8221; &#8220;plan,&#8221; &#8220;goal,&#8221; &#8220;seek,&#8221; &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;likely,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will&#8221; and similar references to future periods.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on Alcon&#8217;s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict. Such forward-looking statements are subject to various risks and uncertainties facing Alcon, including: the impact of the COVID-19 pandemic on its operations and financial results, including the policies and actions taken by governments or other third parties; the commercial success of its products and its ability to maintain and strengthen its position in its markets; the success of its research and development efforts, including its ability to innovate to compete effectively; its success in completing and integrating strategic acquisitions; pricing pressure from changes in third party payor coverage and reimbursement methodologies; global and regional economic, financial, legal, tax, political, and social change; the ability to obtain regulatory clearance and approval of its products as well as compliance with any post-approval obligations, including quality control of its manufacturing; ongoing industry consolidation; its ability to properly educate and train healthcare providers on its products; changes in inventory levels or buying patterns of its customers; its reliance on sole or limited sources of supply; ability to service its debt obligations; the need for additional financing through the issuance of debt or equity; its reliance on outsourcing key business functions; its ability to protect its intellectual property; the impact on unauthorized importation of its products from countries with lower prices to countries with higher prices; the effects of litigation, including product liability lawsuits; its ability to comply with all laws to which it may be subject; effect of product recalls or voluntary market withdrawals; data breaches; the implementation of its enterprise resource planning system; its ability to attract and retain qualified personnel; the accuracy of its accounting estimates and assumptions, including pension plan obligations and the carrying value of intangible assets; legislative and regulatory reform; the ability of Alcon Pharmaceuticals Ltd. to comply with its investment tax incentive agreement with the Swiss State Secretariat for Economic Affairs in Switzerland and the Canton of Fribourg, Switzerland; its ability to operate as a stand-alone company; whether the transitional services Novartis has agreed to provide Alcon are sufficient; the impact of being listed on two stock exchanges; the ability to declare and pay dividends; the different rights afforded to its shareholders as a Swiss corporation compared to a US corporation; and the effect of maintaining or losing its foreign private issuer status under US securities laws. Additional factors are discussed in Alcon&#8217;s filings with the United States Securities and Exchange Commission, including its Form 20-F. Should one or more of these uncertainties or risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated. Therefore, you should not rely on any of these forward-looking statements.</font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">Forward-looking statements in this press release speak only as of the date of its filing, and Alcon assumes no obligation to update forward-looking statements as a result of new information, future events or otherwise.</font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;color:#003595;font-weight:bold;text-decoration:underline;">About Alcon</font></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and </font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10.5pt;"><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">improve people&#8217;s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at </font><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;color:#262fdd;">www.alcon.com</font><font style="font-family:Open Sans,sans-serif;font-size:10.5pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;font-weight:bold;">Connect with us on </font><img src="pressreleaseagmcovid4_image1.gif" alt="pressreleaseagmcovid4_image1.gif" style="height:37px;width:37px;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;font-weight:bold;">&#32;&#32;&#32;&#32;</font><img src="pressreleaseagmcovid4_image2.gif" alt="pressreleaseagmcovid4_image2.gif" style="height:38px;width:41px;"></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div><a name="s7D97BB20B714170594DD5159B6A6A4F9"></a></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;font-weight:bold;text-decoration:underline;">Investor Relations</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">Christina Cheng</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">+ 41 589 112 110 (Geneva)</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">+ 1 817 615 2789 (Fort Worth)</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;color:#0000ff;text-decoration:underline;">investor.relations@alcon.com</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div></div><div style='width:4%; float:left;'>&#160;</div><div style='float:right; width:48%;'><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;font-weight:bold;text-decoration:underline;">Media Relations</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">Wes Warnock</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">+ 41 589 112 111 (Geneva)</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;">+ 1 817 615 2501 (Fort Worth)</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;color:#0000ff;text-decoration:underline;">globalmedia.relations@alcon.com</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Open Sans,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div></div><div><br></div><div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>pressreleaseagmcovid4_image1.gif
<TEXT>
begin 644 pressreleaseagmcovid4_image1.gif
M1TE&.#EA2 !( /(      $)GLDYQMUIZO'&-Q7V7RO___P   "'Y! $
M+     !( $@ 0@C_  $(#$"PH,&#"!,J7,BPH4  #2-*G$BQHL6)  QHW,BQ
M8\>+("-F],@QI$F0(TD:@'BRY4&5,&-N9.G294J2-&OJ1'C38\Z=0 /T[/@S
MJ-&C2!T.A9FTX@"9,IM27#I3:D6H6#T2L&J0@->O7ZEJ! "VK "N$L6N1'M2
M;5&V4V.^G0K7Z-RZ>(^6]7HV;T,!:E7ZY9F5Y&"#@0'T/<S0+>.T<A\7+$SY
M[E'*A>MBQFH9KF/)C2.#7OAY=,+2I@^B3EUPM<7..EU/A<T:<>W;N'/KEDQ
MH$S:< %C-AU8L&3AFPV +L[T<0&H O=ZE1RX@&[9J;$3%YU;.]Z'X!_*0@U/
M'FYRJ-;9GI>YF.MZF,!WOE<97^=\DENI<\?M??G^V_WI!]]N 3Y6(&,''I;@
58 OZU6!>#]IF580$@2=5A \%!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>pressreleaseagmcovid4_image2.gif
<TEXT>
begin 644 pressreleaseagmcovid4_image2.gif
M1TE&.#EABP"  /0       !WM1" NB"(OC"1PT"9R%"BS&"JT7"SUH"[VI#$
MWZ#,X[#5Z,#=[=#F\>#N]O#W^____P
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EKDLC'-4DQCGZ$(5V--P;\Y@VA/$12@7[8Q8#)C!! C!? 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>pressreleaseagmcovid4_image3.gif
<TEXT>
begin 644 pressreleaseagmcovid4_image3.gif
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M-I#'V(8L\L@DEVRR7Y]UZ!D!+_!QC3;"$*,.,<-H0XPPL["[K7<MB#A0 A$
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ME]7"9AGA"$>HX9<S12I\IPG5GV+UJ*=-+Q<.T=K8C@(9R&#&-,:A6WH(5[I
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M(Q% !((@#.#@#A /#OA"!.R"*Q9V(N^Q\*G@\ _O#A*?"D-0\2/B4"W0 T)
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M# 14B$./6K5PH(4^0,0B[,)5L(<JW(=WP 5! ,1)F 0_Z$0/I$-:" >QNX9
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M>B BIM3'"2S*LB1!6OB&H31!"KP$)YQ++M2%S,.&"(3)8MS",@R&('('5HC
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MD%TT;$PG9(4CE8<H[%\79L!WZ$PN)E$GU(1;D& $_E9W:,)-V(1:&%\/U,Y
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M@?\QNJ%@$YJHC)8P<"]9+Q?@ $C:L09W*B+[\ N/[1'7\1WG<;HH-I4 "J
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M (4W" Z() )X@-9O0%]'@ FX>L94>B+W=B(8Y3P$@HTH=T$W_>\'_PSI_L0
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MC][3S<,X/,/6WMMY_=5@_9(KF:T6I$#<L?\L:^$L; &0CN(=!A:*J#32WIJ
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M_S999IE$K;EFG7I@DF<[/VRI\2EY9EK)$ENO25:;:[*D2)B"_-!DHW L&O5
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MQP^8&A $(W'9@]W#MVI1U9O%D2V4T'?_%W/05]<.=D:I7"*2'#6:CE$GTJ&
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M!4KZX#8:AP9388+$)!Q80??\PBL281.^(3(<RAY8+@#;CZ)@CB+\R3^6!/K
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M8[VW< &V-Z'U<O-U6DL67;T6-\WV>T46>.FW?NV7=W&69#TV 2+@>*/2'O8
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M2P#F)EC:;Q& !_8:J;ED'UCZ>Z$XL M[MFF[MO=S>]=V:_D6%9(W)XFA A#
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M:MI4W.'#'0 ""'ZG;&@)(@#!XWL)*A <@""XUYG.344;*#[!(R )?EH@0B*
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MQ%C9X>78FG%'OGC!%NW=O2WBQI@08<<.M! BO.CKH8/,N!0?2(Q !!"N7\"
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MWG\/?OCBCT]^^>:?CW[ZZJ_/?OONOP]__/+/3W_]]M^/?_[Z[\]___[_#\
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MC,>X#\FHC,O(C,WHC,_HC">!$M!(C=7(C,>(C=E8C,$8C+UX#N3P#=[@#=.
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MRG%QUE\,>%D%>9 \*BS! BGW$5+M1)Y]NQ.Y(FHZX7P@]5>Q!I+UN5[Q=6W
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M9-G2Y4.*$E_.C$CQX0B0$EW$Y"FSQ8@-(S .);$!! D2)5+@T-*ET1@U:L:
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M-;C;K @'-J#!>#00'"191"</D6%R9*C"&%J.ADE3F@X[E;Z?X$2/%7DA4D#
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M<L57;,4]I,9]R(=VU,4-6T5XL\5C<41]#,:\^,94="D\L<=T[$9OQ$2!S)V
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M3>[<SM2L"WO0!3OP3$'H T&8ASR<!UIP3<7\ U:@Q7IXA>*T VL(2%C83CM
M!7F J50,AM/<3L_<AM5RS.)DA1RE"WM@!=,,!%8 STN\!W?0A=,4!!_]ST 0
M!%UPA]',SKZLSG"HP^2T _H,!I.Z!U:X3<WLT3^P ]D$C'W8!A^-4B#-"WN
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M(XJ+)7#B(^.A(ABH.4@X8H*J)JWJ1879$+7(H[\ 97$ABN@$.2I3I,@T!'*
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I]5(S=5,[]5-#=51+]513=55;]55C=59K]59S=5=[]5>#=5C?=$   #L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
